StockData
Incannex Healthcare Inc. logo

Incannex Healthcare Inc. (IXHL) stock

IXHLNasdaqPharmaceutical PreparationsFiscal year ends June 30
Financials through Q1 FY2027, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 12, 2026Score 7/30
$1.75+0.01 (+0.57%)

Close on Nov 18, 2026Market cap $21.95MP/E –Yield –

Incannex Healthcare revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

Incannex Healthcare's revenue for the twelve months ending Sep 30, 2025 was $12.00K. For fiscal 2026 it was $0, down 100.0% from the year before. The highest annual figure on record is $1.90M in fiscal 2021.

Annual revenue

PeriodPeriod endValueChange
FY2026Jun 30, 2026$0-100.0%
FY2025Jun 30, 2025$86.00K+616.7%
FY2024Jun 30, 2024$12.00K-99.4%
FY2021Jun 30, 2021$1.90M+213.7%
FY2020Jun 30, 2020$604.88K–

Quarterly revenue

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q1 FY2027CQ3 2026Sep 30, 2026$0-100.0%
Q1 FY2026CQ3 2025Sep 30, 2025$0-100.0%
Q4 FY2025CQ2 2025Jun 30, 2025$0–
Q3 FY2025CQ1 2025Mar 31, 2025$0–
Q2 FY2025CQ4 2024Dec 31, 2024$12.00K–
Q1 FY2025CQ3 2024Sep 30, 2024$74.00K–

More Incannex Healthcare figures

See a number that looks wrong?